CON-TGO91-245 - Phebra Pty Ltd
Product names
- AUST R 23183 - PHEBRA POTASSIUM DIHYDROGEN PHOSPHATE 13.6% (1.361 g in 10 mL) vial potassium phosphate - monobasic 10 mmol/10 mL concentrated injection vial
Sponsor
Decision Date
Duration
The consent is effective for all batches manufactured between 1 September 2020 and 31 August 2021.
Non-compliance with standard
The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.
Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines